1-1 of 1
Melda Dolan
Close
Save search
Sort by
Journal Articles

JBI802 a Highly Potent Corest Inhibitor Demonstrated Anti-Tumor Activity at Low Dose, Thrombocytopenia at Higher Dose NOW Leading to an Opportunity to Treat ET Myeloproliferative Neoplasms (MPN) /Essential Thrombocythemia [ET]) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) with Thrombocytosis

Free
Melda Dolan, Sridharan Rajagopal, Chandru G, Deepak Mittal, Mohd. Zainuddin, Naveen Sadhu, Abhijit Baruah
Journal: Blood
Blood (2024) 144 (Supplement 1): 6648.
https://doi.org/10.1182/blood-2024-209925
Published: 2024